Works matching IS 00070920 AND DT 2013 AND VI 108 AND IP 2

Results: 34

REG Iα is a biomarker for predicting response to chemotherapy with S-1 plus cisplatin in patients with unresectable stage IV gastric cancer.

Published in:

2013

By:

Sekikawa A;
Fukui H;
Zhang X;
Maruo T;
Tsumura T;
Okabe Y;
Wakasa T;
Osaki Y;
Chiba T;
Tomita T;
Oshima T;
Watari J;
Miwa H;
Sekikawa, A;
Fukui, H;
Zhang, X;
Maruo, T;
Tsumura, T;
Okabe, Y;
Wakasa, T

Publication type:

journal article

Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer.

Published in:

2013

By:

Bertorelle R;
Briarava M;
Rampazzo E;
Biasini L;
Agostini M;
Maretto I;
Lonardi S;
Friso ML;
Mescoli C;
Zagonel V;
Nitti D;
De Rossi A;
Pucciarelli S;
Bertorelle, R;
Briarava, M;
Rampazzo, E;
Biasini, L;
Agostini, M;
Maretto, I;
Lonardi, S

Publication type:

journal article

Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis.

Published in:

2013

By:

Procopio G;
Bellmunt J;
Dutcher J;
Bracarda S;
Knox J;
Brueckner A;
Molnar I;
Escudier B;
Hutson TE;
Procopio, G;
Bellmunt, J;
Dutcher, J;
Bracarda, S;
Knox, J;
Brueckner, A;
Molnar, I;
Escudier, B;
Hutson, T E

Publication type:

journal article

Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells.

Published in:

2013

By:

Dixon KM;
Lui GY;
Kovacevic Z;
Zhang D;
Yao M;
Chen Z;
Dong Q;
Assinder SJ;
Richardson DR;
Dixon, K M;
Lui, G Y L;
Kovacevic, Z;
Zhang, D;
Yao, M;
Chen, Z;
Dong, Q;
Assinder, S J;
Richardson, D R

Publication type:

journal article

Functional genomic screening to enhance oncolytic virotherapy.

Published in:

2013

By:

Mahoney DJ;
Stojdl DF;
Mahoney, D J;
Stojdl, D F

Publication type:

journal article

Functional genomic screening to enhance oncolytic virotherapy.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 245, doi. 10.1038/bjc.2012.467

By:

Mahoney, D J;
Stojdl, D F

Publication type:

Article

Effect of sorafenib combined with cytostatic agents on hepatoblastoma cell lines and xenografts.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 334, doi. 10.1038/bjc.2012.539

By:

Eicher, C;
Dewerth, A;
Thomale, J;
Ellerkamp, V;
Hildenbrand, S;
Warmann, S W;
Fuchs, J;
Armeanu-Ebinger, S

Publication type:

Article

Epidural methadone results in dose-dependent analgesia in cancer pain, further enhanced by epidural dexamethasone.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 259, doi. 10.1038/bjc.2012.593

By:

Lauretti, G R;
Rizzo, C C;
Mattos, A L;
Rodrigues, S W

Publication type:

Article

Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 311, doi. 10.1038/bjc.2012.543

By:

Procopio, G;
Bellmunt, J;
Dutcher, J;
Bracarda, S;
Knox, J;
Brueckner, A;
Molnar, I;
Escudier, B;
Hutson, T E

Publication type:

Article

Tissue biomarkers of breast cancer and their association with conventional pathologic features.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 351, doi. 10.1038/bjc.2012.552

By:

Chung, L;
Shibli, S;
Moore, K;
Elder, E E;
Boyle, F M;
Marsh, D J;
Baxter, R C

Publication type:

Article

An intronic polymorphic deletion in the PTEN gene: implications for molecular diagnostic testing.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 438, doi. 10.1038/bjc.2012.562

By:

Sandell, S;
Schuit, R J L;
Bunyan, D J

Publication type:

Article

Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 278, doi. 10.1038/bjc.2012.602

By:

Bertorelle, R;
Briarava, M;
Rampazzo, E;
Biasini, L;
Agostini, M;
Maretto, I;
Lonardi, S;
Friso, M L;
Mescoli, C;
Zagonel, V;
Nitti, D;
De Rossi, A;
Pucciarelli, S

Publication type:

Article

Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 301, doi. 10.1038/bjc.2012.560

By:

Yadegarfar, G;
Friend, L;
Jones, L;
Plum, L M;
Ardill, J;
Taal, B;
Larsson, G;
Jeziorski, K;
Kwekkeboom, D;
Ramage, J K

Publication type:

Article

Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 292, doi. 10.1038/bjc.2012.542

By:

Forbes, L J L;
Simon, A E;
Warburton, F;
Boniface, D;
Brain, K E;
Dessaix, A;
Donnelly, C;
Haynes, K;
Hvidberg, L;
Lagerlund, M;
Lockwood, G;
Tishelman, C;
Vedsted, P;
Vigmostad, M N;
Ramirez, A J;
Wardle, J

Publication type:

Article

Fasting blood glucose is a novel prognostic indicator for extranodal natural killer/T-cell lymphoma, nasal type.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 380, doi. 10.1038/bjc.2012.566

By:

Cai, Q;
Luo, X;
Liang, Y;
Rao, H;
Fang, X;
Jiang, W;
Lin, T;
Huang, H

Publication type:

Article

Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 319, doi. 10.1038/bjc.2012.591

By:

Wang, X;
Zhang, L;
O'Neill, A;
Bahamon, B;
Alsop, D C;
Mier, J W;
Goldberg, S N;
Signoretti, S;
Atkins, M B;
Wood, C G;
Bhatt, R S

Publication type:

Article

Underexpression of tumour suppressor LKB1 in clear cell renal cell carcinoma is common and confers growth advantage in vitro and in vivo.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 327, doi. 10.1038/bjc.2012.574

By:

Duivenvoorden, W C;
Beatty, L K;
Lhotak, S;
Hill, B;
Mak, I;
Paulin, G;
Gallino, D;
Popovic, S;
Austin, R C;
Pinthus, J H

Publication type:

Article

Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 420, doi. 10.1038/bjc.2012.549

By:

Sørensen, K D;
Abildgaard, M O;
Haldrup, C;
Ulhøi, B P;
Kristensen, H;
Strand, S;
Parker, C;
Høyer, S;
Borre, M;
Ørntoft, T F

Publication type:

Article

Lack of correlation between predicted and actual off-target effects of short-interfering RNAs targeting the human papillomavirus type 16 E7 oncogene.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 450, doi. 10.1038/bjc.2012.564

By:

Hanning, J E;
Saini, H K;
Murray, M J;
van Dongen, S;
Davis, M P A;
Barker, E M;
Ward, D M;
Scarpini, C G;
Enright, A J;
Pett, M R;
Coleman, N

Publication type:

Article

Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 429, doi. 10.1038/bjc.2012.538

By:

Pinato, D J;
Ramachandran, R;
Toussi, S T K;
Vergine, M;
Ngo, N;
Sharma, R;
Lloyd, T;
Meeran, K;
Palazzo, F;
Martin, N;
Khoo, B;
Dina, R;
Tan, T M

Publication type:

Article

Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 271, doi. 10.1038/bjc.2012.598

By:

Fisher, G;
Yang, Z H;
Kudahetti, S;
Møller, H;
Scardino, P;
Cuzick, J;
Berney, D M

Publication type:

Article

Erythrocyte sedimentation rate and anaemia are independent predictors of survival in patients with clear cell renal cell carcinoma.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 387, doi. 10.1038/bjc.2012.565

By:

Choi, Y;
Park, B;
Kim, K;
Jeong, B C;
Seo, S I;
Jeon, S S;
Choi, H Y;
Lee, J E;
Lee, H M

Publication type:

Article

Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 409, doi. 10.1038/bjc.2012.582

By:

Dixon, K M;
Lui, G Y L;
Kovacevic, Z;
Zhang, D;
Yao, M;
Chen, Z;
Dong, Q;
Assinder, S J;
Richardson, D R

Publication type:

Article

Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 285, doi. 10.1038/bjc.2012.557

By:

Delpech, Y;
Coutant, C;
Hsu, L;
Barranger, E;
Iwamoto, T;
Barcenas, C H;
Hortobagyi, G N;
Rouzier, R;
Esteva, F J;
Pusztai, L

Publication type:

Article

EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 469, doi. 10.1038/bjc.2012.495

By:

Boeck, S;
Jung, A;
Laubender, R P;
Neumann, J;
Egg, R;
Goritschan, C;
Vehling-Kaiser, U;
Winkelmann, C;
Fischer von Weikersthal, L;
Clemens, M R;
Gauler, T C;
Märten, A;
Klein, S;
Kojouharoff, G;
Barner, M;
Geissler, M;
Greten, T F;
Mansmann, U;
Kirchner, T;
Heinemann, V

Publication type:

Article

An inherited NBN mutation is associated with poor prognosis prostate cancer.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 461, doi. 10.1038/bjc.2012.486

By:

Cybulski, C;
Wokołorczyk, D;
Kluźniak, W;
Jakubowska, A;
Górski, B;
Gronwald, J;
Huzarski, T;
Kashyap, A;
Byrski, T;
Dębniak, T;
Gołąb, A;
Gliniewicz, B;
Sikorski, A;
Świtała, J;
Borkowski, T;
Borkowski, A;
Antczak, A;
Wojnar, Ł;
Przybyła, J;
Sosnowski, M

Publication type:

Article

Targeted anti-vascular therapies for ovarian cancer: current evidence.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 250, doi. 10.1038/bjc.2012.541

By:

Hall, M;
Gourley, C;
McNeish, I;
Ledermann, J;
Gore, M;
Jayson, G;
Perren, T;
Rustin, G;
Kaye, S

Publication type:

Article

A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 342, doi. 10.1038/bjc.2012.576

By:

Kaliszczak, M;
Trousil, S;
Åberg, O;
Perumal, M;
Nguyen, Q-D;
Aboagye, E O

Publication type:

Article

Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 361, doi. 10.1038/bjc.2012.546

By:

Kawaguchi, T;
Komatsu, S;
Ichikawa, D;
Morimura, R;
Tsujiura, M;
Konishi, H;
Takeshita, H;
Nagata, H;
Arita, T;
Hirajima, S;
Shiozaki, A;
Ikoma, H;
Okamoto, K;
Ochiai, T;
Taniguchi, H;
Otsuji, E

Publication type:

Article

The epigenetic landscape of oral squamous cell carcinoma.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 370, doi. 10.1038/bjc.2012.568

By:

Jithesh, P V;
Risk, J M;
Schache, A G;
Dhanda, J;
Lane, B;
Liloglou, T;
Shaw, R J

Publication type:

Article

REG Iα is a biomarker for predicting response to chemotherapy with S-1 plus cisplatin in patients with unresectable stage IV gastric cancer.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 395, doi. 10.1038/bjc.2012.572

By:

Sekikawa, A;
Fukui, H;
Zhang, X;
Maruo, T;
Tsumura, T;
Okabe, Y;
Wakasa, T;
Osaki, Y;
Chiba, T;
Tomita, T;
Oshima, T;
Watari, J;
Miwa, H

Publication type:

Article

Lacking hypoxia-mediated downregulation of E-cadherin in cancers of the uterine cervix.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 402, doi. 10.1038/bjc.2012.570

By:

Mayer, A;
Höckel, M;
Schlischewsky, N;
Schmidberger, H;
Horn, L-C;
Vaupel, P

Publication type:

Article

A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 265, doi. 10.1038/bjc.2012.555

By:

Atmaca, A;
Al-Batran, S-E;
Werner, D;
Pauligk, C;
Güner, T;
Koepke, A;
Bernhard, H;
Wenzel, T;
Banat, A-G;
Brueck, P;
Caca, K;
Prasnikar, N;
Kullmann, F;
Günther Derigs, H;
Koenigsmann, M;
Dingeldein, G;
Neuhaus, T;
Jäger, E

Publication type:

Article

Melatonin induces transcriptional regulation of Bim by FoxO3a in HepG2 cells.

Published in:

British Journal of Cancer, 2013, v. 108, n. 2, p. 442, doi. 10.1038/bjc.2012.563

By:

Carbajo-Pescador, S;
Steinmetz, C;
Kashyap, A;
Lorenz, S;
Mauriz, J L;
Heise, M;
Galle, P R;
González-Gallego, J;
Strand, S

Publication type:

Article